US Patent Issued to AVECHO BIOTECHNOLOGY on Feb. 3 for "Oral cannabinoid formulation comprising tocopheryl phosphates and long chain triglycerides or long chain fatty acids" (Australian Inventor)

ALEXANDRIA, Va., Feb. 3 -- United States Patent no. 12,539,307, issued on Feb. 3, was assigned to AVECHO BIOTECHNOLOGY Ltd. (Clayton, Australia).

"Oral cannabinoid formulation comprising tocopheryl phosphates and long chain triglycerides or long chain fatty acids" was invented by Paul Gavin (Clayton, Australia).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to an oral cannabinoid formulation comprising: a cannabinoid component comprising a cannabinoid; a carrier in the form of long chain triglyceride (LCT) or long chain fatty acid (LCFA); and a tocopheryl phosphate component comprising mono-(tocopheryl) phosphate (TP) and di-(tocopheryl) phosphate (T2P) wherein the mass ratio of the cann...